KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Invested Capital (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of Invested Capital data on record, last reported at $5.3 million in Q4 2025.

  • For Q4 2025, Invested Capital fell 98.94% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 98.94%, while the annual FY2025 figure was $5.3 million, 98.94% down from the prior year.
  • Invested Capital reached $5.3 million in Q4 2025 per PACB's latest filing, down from $36.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.1 billion in Q2 2023 and bottomed at $5.3 million in Q4 2025.
  • Average Invested Capital over 5 years is $539.2 million, with a median of $637.8 million recorded in 2022.
  • Peak YoY movement for Invested Capital: soared 549.29% in 2021, then tumbled 98.94% in 2025.
  • A 5-year view of Invested Capital shows it stood at $791.0 million in 2021, then decreased by 7.08% to $735.0 million in 2022, then decreased by 4.58% to $701.3 million in 2023, then fell by 27.76% to $506.6 million in 2024, then crashed by 98.94% to $5.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $5.3 million in Q4 2025, $36.1 million in Q3 2025, and $61.5 million in Q2 2025.